Back to Search
Start Over
P49 MAGELLAN-1, PART 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic HCV genotype 1 or 4 and prior direct-acting antiviral treatment failure
- Source :
- Journal of Virus Eradication, Vol 3, Iss, Pp 28-29 (2017)
- Publication Year :
- 2017
- Publisher :
- Elsevier, 2017.
Details
- Language :
- English
- ISSN :
- 20556640
- Volume :
- 3
- Database :
- OpenAIRE
- Journal :
- Journal of Virus Eradication
- Accession number :
- edsair.doi.dedup.....3fc81374136673771865501cfd5fb335